The latest biotech news

News and Trends 17 Mar 2020

CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute

The German biotech CureVac — which is developing an mRNA vaccine against coronavirus — has been granted up to €80M by the European Commission, shortly after a dispute erupted over an alleged acquisition offer from the US. The money was awarded to help CureVac quickly scale up the production of its candidate Covid-19 vaccine. It […]

March 17, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 16 Mar 2020

Coronavirus Delays Sensorion’s Hearing Loss Phase II Trial

The French company Sensorion has been forced to delay a phase II trial in people with hearing loss due to slow patient recruitment amid the current coronavirus disease (Covid-19) pandemic. The clinical trial is designed to test Sensorion’s lead candidate drug in people with sudden sensorineural hearing loss, a rare disorder where the patient can […]

March 16, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 13 Mar 2020

Immune Marker in Blood May Predict Kidney Transplant Rejection Risk

French researchers have found that the levels of certain immune cells in the blood of kidney transplant recipients may predict their future risk for transplant rejection. At present, kidney transplantation is the best treatment for people with end-stage renal disease but introducing a ‘foreign’ organ into someone’s body comes with the risk of rejection by […]

March 13, 2020 - 3 minutesmins - By Laura Cowen

News and Trends 12 Mar 2020

Gedea Biotech’s Bacterial Vaginosis Tablet Proves As Good as Antibiotics

An antibiotic-free vaginal tablet developed by the Swedish company Gedea Biotech has cured 82% of women of the common vaginal infection bacterial vaginosis in a 24-patient clinical trial. Bacterial vaginosis occurs when the normal vaginal microflora — characterized by a high proportion of bacteria from the genus Lactobacillus — become unbalanced with an overgrowth of […]

March 12, 2020 - 3 minutesmins - By Laura Cowen

multiple sclerosis neuron sheath medday Pharma

News and Trends 11 Mar 2020

Phase III Fail for MedDay’s Multiple Sclerosis Treatment

A drug developed by the French company MedDay Pharmaceuticals has failed to treat progressive forms of multiple sclerosis in a phase III trial. The 642 patients recruited into the trial received either a placebo or a high dose of pharmaceutical-grade Biotin, also known as vitamin B₇. The patients had various forms of the autoimmune condition […]

March 11, 2020 - 2 minutesmins - By Jonathan Smith

News and Trends 11 Mar 2020

Update: Carmat’s Artificial Heart Reaches Two Year Milestone

Update (11/03/2020): In a record first, Carmat announced today that one patient in its artificial heart trial has had the device implanted for 2 years. “Passing a two-year period of individual functioning is very encouraging, and confirms the capacity of our device to provide long-term support, which is one of our two key objectives along […]

March 11, 2020 - 3 minutesmins - By Jonathan Smith

News and Trends 10 Mar 2020

LSP Raises €528M in Largest European Life Sciences Investment Fund

Healthcare investor Life Sciences Partners has closed the largest ever European venture capital fund dedicated to new medicines and technologies after raising €528M. LSP 6, the company’s largest private equity fund to date, attracted significantly more than the original €396M target from a diverse investor group that included governments and the EU-supported European Investment Fund. […]

March 10, 2020 - 2 minutesmins - By External Contributor

News and Trends 5 Mar 2020

Drug Development Costs Lower Than Pharma Companies Claim

A team of UK and Belgian scientists has reported that drug companies spend up to €1.3B less on drug development than previously suggested, which raises questions about high drug prices set by some biotech and pharma companies. The study, published in the journal JAMA, took publicly available data from pharma company financial reports with the […]

March 5, 2020 - 4 minutesmins - By Jonathan Smith

News and Trends 4 Mar 2020

Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B

UK biotech Immunocore has raised €116.7M in Series B funding to develop drugs that harness the body’s immune cells to fight cancer, viral infections, and autoimmune diseases. This latest funding round for the company, which specializes in redirecting and activating T-cells, includes an international group of new investors led by the US private equity firm […]

March 4, 2020 - 2 minutesmins - By External Contributor

News and Trends 4 Mar 2020

CN Bio Raises €8M to Boost Organ-on-a-Chip Rollout

UK cell culture specialist CN Bio Innovations has secured €7.98M (£7M) from Chinese investors to bolster its US market and expand European activities. Investment in the bioengineering company was led by Chinese investor CITIC Securities Company and with further support from existing Hong Kong-based investor CN Innovations Holdings. CN Bio, which creates benchtop instruments to […]

March 4, 2020 - 3 minutesmins - By External Contributor

News and Trends 3 Mar 2020

Alnylam Gets Second RNAi Drug Approval from EMA

US biotech Alnylam Pharmaceuticals has succeeded in getting its second RNAi drug — for treatment of rare, inherited liver diseases — approved by the European Medicines Authority just months after achieving US FDA approval for the same drug. Alnylam are well known for being pioneers in the RNA interference space. The company achieved the first […]

March 3, 2020 - 2 minutesmins - By Helen Albert

News and Trends 2 Mar 2020

Evonetix Raises €27M Series B to Progress DNA Synthesis Technology

UK synthetic biology company Evonetix raised €27M in Series B funding to develop its fast DNA synthesis technology and produce a working prototype of the company’s desktop platform. New investor Foresite Capital, a US-based VC firm, led the round, although all the company’s earlier Series A investors, such as the tech-focused VC’s Draper Esprit and […]

March 2, 2020 - 2 minutesmins - By Helen Albert

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

CureVac Receives €80M from EU to Fund Coronavirus Vaccine Amid US Dispute

Coronavirus Delays Sensorion’s Hearing Loss Phase II Trial

Immune Marker in Blood May Predict Kidney Transplant Rejection Risk

Gedea Biotech’s Bacterial Vaginosis Tablet Proves As Good as Antibiotics

Phase III Fail for MedDay’s Multiple Sclerosis Treatment

Update: Carmat’s Artificial Heart Reaches Two Year Milestone

LSP Raises €528M in Largest European Life Sciences Investment Fund

Drug Development Costs Lower Than Pharma Companies Claim

Immunocore Raises €117M to Develop Immunotherapies for Cancer and Hepatitis B

CN Bio Raises €8M to Boost Organ-on-a-Chip Rollout

Alnylam Gets Second RNAi Drug Approval from EMA

Evonetix Raises €27M Series B to Progress DNA Synthesis Technology

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!